Evidence map›Paper›PMID 32617026›Full record

ArticleHepatic medicine : evidence and research2020

Effect of Oral Administration of

Fouad M F Elshaghabee, Darab Ghadimi, Diana Habermann, Michael de Vrese, Wilhelm Bockelmann, Hans-Jürgen Kaatsch, Knut J Heller, Jürgen Schrezenmeir

Open access · goldAbstract read
In one paragraph

Article in Hepatic medicine : evidence and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Gut microbes reports · 2026
    Article
  4. Article
  5. Frontiers in microbiology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Weissella: An Emerging Bacterium with Promising Health Benefits.Probiotics and antimicrobial proteins · 2021
    Review
  12. Complete Genome Sequence ofFrontiers in microbiology · 2021
    Article
  13. Food & nutrition research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fouad M F ElshaghabeeMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.
Darab GhadimiMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.
Diana HabermannMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.ORCID 0000-0001-9710-5172
Michael de VreseMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.
Wilhelm BockelmannMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.
Hans-Jürgen KaatschInstitute of Legal Medicine, University Hospital of Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-4312-5626
Knut J HellerMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Microbiology and Biotechnology, Kiel, Germany.ORCID 0000-0003-1757-8805
Jürgen SchrezenmeirMax Rubner-Institute, Federal Research Institute of Nutrition and Food, Department of Physiology and Biochemistry of Nutrition, Karlsruhe, Germany.
Max Rubner Institut · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeIn previous investigations, MATERIALS AND

methodsFrom week 1 to 6, rats were given a medium fructose and fat (MFru-MF) diet containing 28% fructose and 10% fat without the addition of

resultsIn HFru-HF-fed rats, DISCUSSION: This is the first in vivo trial demonstrating that heterofermentative lactic acid bacteria lacking the mannitol pathway (like

Indexed as

fecal ethanolfecal short-chain fatty acidsglycemiahigh fructose-high fat dietlipidemiaNAFLD

Identifiers

PMID32617026
PMCPMC7326399
OpenAlexW3037198647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.